« Cytokinetics Announces Fundamental Research in the Field of Cardiac Myosin … – PR-USA.net (press release) | Home | Four Non-Profits Covering the Spectrum of Neurodegenerative Disease … – PR Newswire (press release) »
Who’s Going to Pay for Future Drug Development? (Part 1) – Xconomy
By | March 22, 2011
->
|
Who's Going to Pay for Future Drug Development? (Part 1)
Xconomy There are still no effective treatments for Parkinson's disease, amyotrophic lateral sclerosis, muscular dystrophy, and a huge number of other illnesses. The number of new medicines being brought to market has been declining in recent years at a time … |
Topics: Uncategorized | No Comments »
